Nomura Asset Management CO LTD Bio N Tech Se Transaction History

Nomura Asset Management CO LTD

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share
Q3 2024 Nov 15, 2024	BUY	$78.36 - $124.66 $0 - $0
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $0 - $0
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $0 - $0
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $0 - $0
Q3 2023 Nov 03, 2023	BUY	$98.5 - $125.08 $0 - $0
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $0 - $0
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$127.65 - $183.11 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$127.65 - $183.11 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $0 - $0
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$216.64 - $362.52 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $0 - $0

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.